Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -20.16 Billion JPY | 56.97% |
| 2023 | -46.86 Billion JPY | 8.94% |
| 2022 | -51.47 Billion JPY | -15.65% |
| 2021 | -44.5 Billion JPY | -31.07% |
| 2020 | -33.95 Billion JPY | 33.0% |
| 2019 | -50.67 Billion JPY | 16.79% |
| 2018 | -60.9 Billion JPY | -6.41% |
| 2017 | -57.24 Billion JPY | -2.95% |
| 2016 | -55.59 Billion JPY | -11.04% |
| 2015 | -50.07 Billion JPY | -41.88% |
| 2014 | -35.29 Billion JPY | -5.1% |
| 2013 | -33.58 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -42.74 Billion JPY | -14.75% |
| 2024 FY | -20.16 Billion JPY | 56.97% |
| 2024 Q3 | -9.32 Billion JPY | 78.19% |
| 2024 Q4 | -20.16 Billion JPY | -116.37% |
| 2024 Q1 | -37.25 Billion JPY | 20.52% |
| 2023 Q4 | -46.86 Billion JPY | -43.07% |
| 2023 Q2 | -45.34 Billion JPY | -46.32% |
| 2023 Q1 | -30.98 Billion JPY | 39.8% |
| 2023 FY | -46.86 Billion JPY | 8.94% |
| 2023 Q3 | -32.75 Billion JPY | 27.75% |
| 2022 Q2 | -57.23 Billion JPY | -39.81% |
| 2022 FY | -51.47 Billion JPY | -15.65% |
| 2022 Q3 | -52.5 Billion JPY | 8.26% |
| 2022 Q4 | -51.47 Billion JPY | 1.97% |
| 2022 Q1 | -40.93 Billion JPY | 8.02% |
| 2021 Q3 | -39.3 Billion JPY | -0.86% |
| 2021 Q2 | -38.96 Billion JPY | -20.48% |
| 2021 FY | -44.5 Billion JPY | -31.07% |
| 2021 Q1 | -32.34 Billion JPY | 18.44% |
| 2021 Q4 | -44.5 Billion JPY | -13.23% |
| 2020 Q1 | -30.26 Billion JPY | 40.5% |
| 2020 Q4 | -39.65 Billion JPY | -25.45% |
| 2020 Q3 | -31.61 Billion JPY | 21.28% |
| 2020 Q2 | -40.15 Billion JPY | -32.67% |
| 2020 FY | -33.95 Billion JPY | 33.0% |
| 2019 Q1 | -51.14 Billion JPY | 16.28% |
| 2019 Q3 | -45.88 Billion JPY | 9.75% |
| 2019 Q4 | -50.87 Billion JPY | -10.86% |
| 2019 Q2 | -50.84 Billion JPY | 0.59% |
| 2019 FY | -50.67 Billion JPY | 16.79% |
| 2018 Q4 | -61.08 Billion JPY | -11.04% |
| 2018 FY | -60.9 Billion JPY | -6.41% |
| 2018 Q1 | -46.04 Billion JPY | 19.79% |
| 2018 Q2 | -55.06 Billion JPY | -19.59% |
| 2018 Q3 | -55.01 Billion JPY | 0.1% |
| 2017 Q1 | -42.59 Billion JPY | 23.67% |
| 2017 Q2 | -53.67 Billion JPY | -26.01% |
| 2017 Q4 | -57.41 Billion JPY | -17.39% |
| 2017 Q3 | -48.9 Billion JPY | 8.89% |
| 2017 FY | -57.24 Billion JPY | -2.95% |
| 2016 FY | -55.59 Billion JPY | -11.04% |
| 2016 Q4 | -55.81 Billion JPY | -14.75% |
| 2016 Q3 | -48.63 Billion JPY | 6.87% |
| 2016 Q2 | -52.22 Billion JPY | -20.66% |
| 2016 Q1 | -43.28 Billion JPY | 13.55% |
| 2015 Q4 | -50.07 Billion JPY | -20.17% |
| 2015 Q3 | -41.67 Billion JPY | -5.36% |
| 2015 Q2 | -39.54 Billion JPY | -30.94% |
| 2015 Q1 | -30.2 Billion JPY | 14.41% |
| 2015 FY | -50.07 Billion JPY | -41.88% |
| 2014 FY | -35.29 Billion JPY | -5.1% |
| 2014 Q4 | -35.29 Billion JPY | -32.46% |
| 2014 Q3 | -26.64 Billion JPY | 8.57% |
| 2014 Q2 | -29.14 Billion JPY | -3.08% |
| 2014 Q1 | -28.26 Billion JPY | 15.82% |
| 2013 Q4 | -33.58 Billion JPY | -29.38% |
| 2013 Q2 | -27.15 Billion JPY | 0.0% |
| 2013 FY | -33.58 Billion JPY | 0.0% |
| 2013 Q3 | -25.95 Billion JPY | 4.41% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 4204999.183% |
| Ansell Limited | -54.99 Million USD | -36571.177% |
| Ansell Limited | -55.1 Million USD | -36502.541% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | -55165.142% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -19188878.326% |
| Psykey, Inc. | 634.59 Thousand USD | 3178199.979% |
| ConvaTec Group Plc | 1.2 Billion USD | 1779.823% |
| ConvaTec Group Plc | 1.2 Billion USD | 1777.452% |
| Encision Inc. | 1.29 Million USD | 1562671.425% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 873658.777% |
| Innovative MedTech Inc. | 1.76 Million USD | 1142933.829% |
| LifePoint, Inc. | -3.26 Million USD | -617788.181% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 411340.855% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 932939.963% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -46572964.844% |
| Reflect Scientific, Inc. | -1.03 Million USD | -1947921.215% |
| SmileDirectClub, Inc. | 778.67 Million USD | 2690.034% |
| Sector 10, Inc. | 163 Thousand USD | 12373106.135% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | -4730.031% |
| SheerVision, Inc. | 57.34 Thousand USD | 35167234.562% |
| United Health Products, Inc. | 660.56 Thousand USD | 3053225.412% |
| Vasamed, Inc. | 22.12 Thousand USD | 91167263.909% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 766588.84% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 2611591.443% |